Does additional HIPEC help after CRS in peritoneal disseminated gastric cancer?

Publié en ligne: 09 mars 2018

Pages: 187 - 189

Reçu: 29 sept. 2017

Accepté: 29 déc. 2017

DOI: https://doi.org/10.1515/cipms-2017-0035

Mots clés

gastric adenocarcinoma, hyperthermic intraperitoneal chemotherapy (HIPEC), peritoneal metastasis, peritoneal carcinomatosis, GASTRIPEC trial

© 2017 Beate Rau et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.